Compre Aqui
Anterior
Referências
2.Winston MH, Shalita AR. Acne vulgaris. Pathogenesis and treatment. Pediat Clin North Am. 1991; 38(4):889-903.
3.Ribeiro BM, Almeida LMC, Costa A, Francesconi F, Follador I, Neves JR. Etiopathogeny of acne vulgaris: a practical review for day-to-day dermatologic practice. Surg Cosmet Dermatol 2015;7(3 Suppl 1): S20-6.
4.Rocha MA, Costa CS, Bagatin E. Acne vulgaris: an inflammatory disease even before the onset of clinical lesions. Inflamm Allergy Drug Targets. 2014;13(3):162-7.
5. Bowe WP, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future? Gut Pathogens 2011, 3:1.
6.Bowe WP, Patel NB, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis: from anecdote to translational medicine. Benefcial Microbes, 2014; 5(2): 185-199;
7.Michaëlsson G, Juhlin L, Vahlquist A. E?ect of Oral Zinc and Vitamin A in Acne. Arch. Dermatol. 1977; 113: 312-36;
8.Butool F, Amanullah M. Signifcance of Serum Copper Levels in Patients with Acne Vulgaris. Cosmetol & Oro Facial Surg 2018, 4:2;
9.Michaëlsson G. Diet and acne. Nutr Rev. 1981; 39: 104-6;
10.Khalil, S. and col. Retinoids: a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse e?ects. Journal of Dermatological Treatment, 2017 28(8), 684-696;
11.Van Vloten WA, Bos LP. Skin lesions in acquired zinc defciency due to parenteral nutrition. Dermatologica, 1978;156:175-83;
12.Rotulagem do produto Exímia Probiac.
Exímia Probiac
Probiac
Primeiro nutracêutico com probióticos, vitaminas e minerais para o cuidado da acne1-2
- Equilibra as alterações intestinais que são comuns em pessoas com acne1, 3-8
- Auxilia a melhora da inflamação na corrente sanguínea, controlando a produção excessiva de sebo e o entupimento de poros1, 3-8
Modo de Uso: Tomar 1 comp. branco + 1 comp. verde – 1 vez ao dia2
Composição: Comprimido branco: associação de 2 probióticos: Lactobacillus acidophilus NCFM® + Bifidobacterium lactis HN0192 Comprimido verde: Vitaminas A, B6 e Niacina e Minerais Zn e Cu em 100% da IDR2
Referências
Referência
1.Figueiredo A, Massa A, Picoto A, Soares AP, Basto AS, Lopes C, et al. Avaliação e tratamento do doente com acne – Parte I: Epidemiologia, etiopatogenia, clínica, classificação, impacto psicossocial, mitos e realidades, diagnóstico diferencial e estudos complementares. Rev Port Clin Geral. 2011 Jan-Feb;27:59-65.2.Winston MH, Shalita AR. Acne vulgaris. Pathogenesis and treatment. Pediat Clin North Am. 1991; 38(4):889-903.
3.Ribeiro BM, Almeida LMC, Costa A, Francesconi F, Follador I, Neves JR. Etiopathogeny of acne vulgaris: a practical review for day-to-day dermatologic practice. Surg Cosmet Dermatol 2015;7(3 Suppl 1): S20-6.
4.Rocha MA, Costa CS, Bagatin E. Acne vulgaris: an inflammatory disease even before the onset of clinical lesions. Inflamm Allergy Drug Targets. 2014;13(3):162-7.
5. Bowe WP, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future? Gut Pathogens 2011, 3:1.
6.Bowe WP, Patel NB, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis: from anecdote to translational medicine. Benefcial Microbes, 2014; 5(2): 185-199;
7.Michaëlsson G, Juhlin L, Vahlquist A. E?ect of Oral Zinc and Vitamin A in Acne. Arch. Dermatol. 1977; 113: 312-36;
8.Butool F, Amanullah M. Signifcance of Serum Copper Levels in Patients with Acne Vulgaris. Cosmetol & Oro Facial Surg 2018, 4:2;
9.Michaëlsson G. Diet and acne. Nutr Rev. 1981; 39: 104-6;
10.Khalil, S. and col. Retinoids: a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse e?ects. Journal of Dermatological Treatment, 2017 28(8), 684-696;
11.Van Vloten WA, Bos LP. Skin lesions in acquired zinc defciency due to parenteral nutrition. Dermatologica, 1978;156:175-83;
12.Rotulagem do produto Exímia Probiac.
